KAT5, a HAT of the MYST family, has been identified as a haploinsufficient tumor suppressor, and loss or low expression of KAT5 was observed in a fraction of breast cancer cases, correlating with poor prognosis [18, 19]. This evidence concerns the gene KAT5 and breast carcinoma.